Why Novo Nordisk (NVO) is a Great Dividend Stock Right Now

Company Overview - Novo Nordisk (NVO) is headquartered in Bagsvaerd and operates in the Medical sector [3] - The stock has experienced a price decline of 13.58% since the beginning of the year [3] Dividend Information - Novo Nordisk currently pays a dividend of $0.82 per share, resulting in a dividend yield of 2.2% [3] - The company's annualized dividend of $1.64 has increased by 59.8% compared to the previous year [4] - Over the past five years, Novo Nordisk has raised its dividend five times, averaging an annual increase of 22.48% [4] - The current payout ratio is 48%, indicating that the company distributes 48% of its trailing 12-month earnings per share as dividends [4] Earnings Expectations - The Zacks Consensus Estimate for Novo Nordisk's earnings in 2025 is projected at $3.87 per share, reflecting a year-over-year growth rate of 17.99% [5] Investment Considerations - Novo Nordisk is considered a compelling investment opportunity due to its strong dividend profile and current Zacks Rank of 3 (Hold) [7] - The company is positioned well for income investors, especially in contrast to tech start-ups and growth businesses that typically do not offer dividends [6][7]